Intercept Pharmaceuticals (ICPT) Prices IPO at $15 Per Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Intercept Pharmaceuticals (ICPT) IPO Trades 26% Higher
October 11, 2012 11:39 AM EDTThe IPO for Intercept Pharmaceuticals, Inc., (Nasdaq: ICPT) opened for trading earlier at $19.40 after pricing 5,000,000 shares at $15, the high end of the expected $13-$15 range. Shares currently trade at $18.87.
BofA Merrill Lynch is acting as sole book-running manager for the... More



